🎉 M&A multiples are live!
Check it out!

Precigen Valuation Multiples

Discover revenue and EBITDA valuation multiples for Precigen and similar public comparables like Pharming, Benevolent AI, and Vivoryon Therapeutics.

Precigen Overview

About Precigen

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.


Founded

1998

HQ

United States of America
Employees

143

Website

precigen.com

Financials

LTM Revenue $6.0M

LTM EBITDA -$121M

EV

$319M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Precigen Financials

Precigen has a last 12-month revenue of $6.0M and a last 12-month EBITDA of -$121M.

In the most recent fiscal year, Precigen achieved revenue of $3.9M and an EBITDA of -$123M.

Precigen expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Precigen valuation multiples based on analyst estimates

Precigen P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $6.2M $3.9M XXX XXX XXX
Gross Profit $20.6M $0.1M XXX XXX XXX
Gross Margin 330% 3% XXX XXX XXX
EBITDA -$89.2M -$123M XXX XXX XXX
EBITDA Margin -1433% -3146% XXX XXX XXX
Net Profit $28.3M -$95.9M XXX XXX XXX
Net Margin 455% -2443% XXX XXX XXX
Net Debt $38.4M n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Precigen Stock Performance

As of April 15, 2025, Precigen's stock price is $1.

Precigen has current market cap of $412M, and EV of $319M.

See Precigen trading valuation data

Precigen Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$319M $412M XXX XXX XXX XXX $-0.41

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Precigen Valuation Multiples

As of April 15, 2025, Precigen has market cap of $412M and EV of $319M.

Precigen's trades at 53.2x LTM EV/Revenue multiple, and -2.6x LTM EBITDA.

Analysts estimate Precigen's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Precigen and 10K+ public comps

Precigen Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $319M XXX XXX XXX
EV/Revenue 81.3x XXX XXX XXX
EV/EBITDA -2.6x XXX XXX XXX
P/E -3.3x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -4.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Precigen Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Precigen Valuation Multiples

Precigen's NTM/LTM revenue growth is 669%

Precigen's revenue per employee for the last fiscal year averaged $27K, while opex per employee averaged $0.7M for the same period.

Over next 12 months, Precigen's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Precigen's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Precigen and other 10K+ public comps

Precigen Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -37% XXX XXX XXX XXX
EBITDA Margin -3146% XXX XXX XXX XXX
EBITDA Growth 38% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -2477% XXX XXX XXX XXX
Revenue per Employee $27K XXX XXX XXX XXX
Opex per Employee $0.7M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 1352% XXX XXX XXX XXX
Opex to Revenue 2404% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Precigen Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Precigen M&A and Investment Activity

Precigen acquired  XXX companies to date.

Last acquisition by Precigen was  XXXXXXXX, XXXXX XXXXX XXXXXX . Precigen acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Precigen

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Precigen

When was Precigen founded? Precigen was founded in 1998.
Where is Precigen headquartered? Precigen is headquartered in United States of America.
How many employees does Precigen have? As of today, Precigen has 143 employees.
Who is the CEO of Precigen? Precigen's CEO is Dr. Helen Sabzevari, PhD.
Is Precigen publicy listed? Yes, Precigen is a public company listed on NAS.
What is the stock symbol of Precigen? Precigen trades under PGEN ticker.
When did Precigen go public? Precigen went public in 2013.
Who are competitors of Precigen? Similar companies to Precigen include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Precigen? Precigen's current market cap is $412M
What is the current revenue of Precigen? Precigen's last 12-month revenue is $6.0M.
What is the current EBITDA of Precigen? Precigen's last 12-month EBITDA is -$121M.
What is the current EV/Revenue multiple of Precigen? Current revenue multiple of Precigen is 53.2x.
What is the current EV/EBITDA multiple of Precigen? Current EBITDA multiple of Precigen is -2.6x.
What is the current revenue growth of Precigen? Precigen revenue growth between 2023 and 2024 was -37%.
Is Precigen profitable? Yes, Precigen is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.